RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 8 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $13,118,000 | 65.48% |
| Flagship Pioneering Inc. | 38,296,526 | $191,866,000 | 5.30% |
| Abbot Financial Management, Inc. | 563,500 | $2,823,000 | 1.83% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,944,000 | 1.83% |
| Artal Group S.A. | 3,778,913 | $18,932,000 | 0.46% |
| Virtus ETF Advisers LLC | 50,863 | $255,000 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 402,555 | $2,017,000 | 0.02% |
| PDT Partners, LLC | 49,500 | $248,000 | 0.02% |
| Baillie Gifford | 4,273,861 | $21,413,000 | 0.02% |
| Trexquant Investment LP | 36,363 | $182,000 | 0.01% |